Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

Published Date: 28 Jun 2024

Adding the mTOR inhibitor didn't improve EFS in intermediate-risk rhabdomyosarcoma

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Bayer is transforming pharmaceutical research into women's health

2.

Palliative Care Remains Uncommon in Young Adults With Cancer

3.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

4.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

5.

healthy despite having advanced cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot